Allergen immunotherapy for respiratory allergies in clinical practice: A comprehensive review
Allergen-specific immunotherapy (AIT) is the only treatment that modifies the underlying pathophysiology of IgE-mediated allergic diseases.
Binding and neutralizing antibody levels and vaccine efficacy/effectiveness compared between heterologous and homologous primary series COVID-19 vaccination: A systematic review and meta-analysis
The data on the immunogenicity and efficacy of heterologous primary series COVID-19 vaccination are still limited.
As-needed versus regular intranasal corticosteroid for allergic rhinitis: A systematic review and meta-analysis
Daily intranasal corticosteroid (INCS) is recommended for treating allergic rhinitis (AR). Nevertheless, patients are generally not adherent and use it on-demand. The data on the efficacy of as-needed INCS was insufficient.
Guidelines for the management of asthma in adults: Evidence and recommendations
The multidisciplinary experts in Thailand developed an asthma management recommendation that was relevant to low-middle income countries (LMICS). Population level consideration about asthma management is emphasized.
Biological therapy in Psoriasis: An emphasis on its dermatologic adverse events
Review Article Biological therapy in Psoriasis: An emphasis on its dermatologic adverse events Pasita Palakornkitti,1 Kulsupa Nimmannitya,1 Ploysyne Rattanakaemakorn1 1 Division of Dermatology, Department of Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand Abstract Objective: To report...
Innate immunity in COVID-19: Drivers of pathogenesis and potential therapeutic targets
A novel severe acute respiratory syndrome COVID-19 caused by coronavirus SARS-CoV-2 has been confirmed to infect more than 100 million people globally, with mortality reaching nearly 3 million as of March 2021.
Clinical practice guidelines for the diagnosis and management of atopic dermatitis
Atopic dermatitis (AD), a chronic, relapsing dermatitis, is characterized by dry and pruritus skin in patients with a personal or family history of atopy. It affects up to 20% of children and 1-3% of adults in most countries worldwide, and leads to significant treatment costs and morbidity.
Nocturnal asthma
Nocturnal asthma has unique pathophysiological mechanisms, comorbid diseases, and intervention. Even though the treatments for asthma have been highly developed, there are a high number of patients with asthma whose symptoms are not well controlled, particularly those with nocturnal asthma in which symptoms occur during the night and interfere with sleep.
Asthma does not increase COVID-19 mortality and poor outcomes: A systematic review and meta-analysis
The Center for Disease Control and Prevention (CDC) has mentioned Coronavirus Disease 2019 (COVID-19) patients with moderate or severe asthma as a high risk group for severe illness. While WHO mentioned only chronic respiratory diseases, not specifically asthma as a risk factor for severe illness. There has been asthma prevalence discrepancy in studies of COVID-19 across the world.